A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab

Primary biliary cirrhosis (PBC) is a progressive liver disease for which limited therapies are recommended. Rituximab, an anti-CD20 monoclonal antibody, is expected to be a useful therapeutic regimen for PBC. Previous studies indicated biochemical and immunological improvement in PBC after rituximab...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajiri, Kazuto, Tsuneyama, Koichi, Miyazono, Takahiro, Kawai, Kengo, Minemura, Masami, Sugiyama, Toshiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: April, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656669/
https://www.ncbi.nlm.nih.gov/pubmed/23687488
http://dx.doi.org/10.1159/000351173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656669/
https://www.ncbi.nlm.nih.gov/pubmed/23687488
http://dx.doi.org/10.1159/000351173

Ejemplares similares